Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willemijn de Klaver

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[Less surveillance colonoscopies needed: implications of the update of the Dutch colonoscopy surveillance guideline]Willemijn de Klaver, Monique E van Leerdam, Evelien Dekker
Gastroenterology|November 3, 2024
ReplyWillemijn de Klaver, Manon van der Vlugt, Evelien Dekker
Cancer Treatment Reviews|April 24, 2016
The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancerWendy Onstenk, Willemijn de Klaver, Ronald de Wit, et al.
Expert Review of Molecular Diagnostics|November 6, 2023
Cross-sectional risk models using quantitative fecal hemoglobin in colorectal cancer screening: a systematic reviewTim Kortlever, Willemijn de Klaver, Manon van der Vlugt, et al.
Gastroenterology|May 2, 2024
Risk of Cancers Proximal to the Colon in Fecal Immunochemical Test Positive Screenees in a Colorectal Cancer Screening ProgramWillemijn de Klaver, Manon van der Vlugt, Manon C W Spaander, et al.
The Journal of Pathology|March 29, 2024
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening settingWillemijn de Klaver, Meike de Wit, Anne Bolijn, et al.
Annals of Internal Medicine|July 19, 2021
Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy StudyWillemijn de Klaver, Pieter H A Wisse, Francine van Wifferen, et al.
Gut|April 15, 2019
Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort studyArne Gc Bleijenberg, Joep Eg IJspeert, Yasmijn J van Herwaarden, et al.
The Lancet. Oncology|February 12, 2024
The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention studyPieter H A Wisse, Willemijn de Klaver, Francine van Wifferen, et al.
Gut|July 18, 2023
An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principlesRobert S Bresalier, Carlo Senore, Graeme P Young, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[Less surveillance colonoscopies needed: implications of the update of the Dutch colonoscopy surveillance guideline]Willemijn de Klaver, Monique E van Leerdam, Evelien Dekker
Gastroenterology|November 3, 2024
ReplyWillemijn de Klaver, Manon van der Vlugt, Evelien Dekker
Cancer Treatment Reviews|April 24, 2016
The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancerWendy Onstenk, Willemijn de Klaver, Ronald de Wit, et al.
Expert Review of Molecular Diagnostics|November 6, 2023
Cross-sectional risk models using quantitative fecal hemoglobin in colorectal cancer screening: a systematic reviewTim Kortlever, Willemijn de Klaver, Manon van der Vlugt, et al.
Gastroenterology|May 2, 2024
Risk of Cancers Proximal to the Colon in Fecal Immunochemical Test Positive Screenees in a Colorectal Cancer Screening ProgramWillemijn de Klaver, Manon van der Vlugt, Manon C W Spaander, et al.
The Journal of Pathology|March 29, 2024
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening settingWillemijn de Klaver, Meike de Wit, Anne Bolijn, et al.
Annals of Internal Medicine|July 19, 2021
Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy StudyWillemijn de Klaver, Pieter H A Wisse, Francine van Wifferen, et al.
Gut|April 15, 2019
Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort studyArne Gc Bleijenberg, Joep Eg IJspeert, Yasmijn J van Herwaarden, et al.
The Lancet. Oncology|February 12, 2024
The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention studyPieter H A Wisse, Willemijn de Klaver, Francine van Wifferen, et al.
Gut|July 18, 2023
An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principlesRobert S Bresalier, Carlo Senore, Graeme P Young, et al.
Pageof 2